In The News: 08/04

Alendronate: Staying Power For Osteoporosis Patients The osteoporosis drug alendronate (Fosamax), a non-hormonal medication which slows bone loss and increases bone density by promoting bone mineralization, continues to help prevent bone loss years after patients stop taking it. A 10-year study among 247 post-menopausal women found that bone mineral density in the spine increased nearly 14 percent among those who took 10mg of alendronate daily for 10 years. Patients who took 20mg of the drug daily…
To continue reading this article or issue you must be a paid subscriber. Sign in

Subscribe to Arthritis Advisor

Get the next year of Arthritis Advisor for just $20. And access all of our online content - over 1,000 articles - free of charge.
Subscribe today and save 36%. It's like getting 4 months FREE!
Already Subscribed?
Click Here to Sign In | Forgot your password? | Activate Web Access